Boston is gaining momentum as a hub for biotechnology research, but San Francisco is not quietly giving up the spot as a top hub, writes Luke Timmerman. San Francisco offers a feeling of expansiveness while Boston packs industry, investors, researchers and hospitals into a tight geographic space, offering a feeling of closeness, says Una Ryan, the former Avant Immunotherapeutics CEO who recently moved from Boston to San Francisco. Though both cities have done much to build their biotech economies, neither can afford to rest, Timmerman notes.
Boston and San Francisco compete for biotech momentum
SmartBrief Job Listings for Health Care
|Account Management and Product Development Specialist||
Sharp Health Plan
|San Diego, CA|
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.